This view is intended for Health Care Professionals (HCP) only. If you are not an HCP
Open

Clinical Studies

share via e-mail

The Safety and Effect Study of Acupuncture for Anorexia in Patients with Gastrointestinal Tract and Lung Cancers

Purpose This trail will be carried out to evaluated the effect and safety of acupuncture for the anorexia in patients with gastrointestinal tract and lung cancers.
Recruitment This study is currently recruiting participants.
Conditio Cancer Cachexia
Intervention Other: Acupuncture
Other: Sham Acupuncture
Drug: Megestrol Acetate
Drug: Placebo (Megestrol Acetate)
Outcome Measures
Primary Outcome Measures:
  • Appetite Visual Analog Scale [Time Frame: Baseline, the days 8 and 15.] [Designated as safety issue: No].
    The assessment will be done thirty minutes before meals. The participators should record the score of their appetite (0 to 100 mm) the higher scores reflect better symptom control.
Secondary Outcome Measures:
  • Council of Nutrition appetite questionnaire (CNAQ) [Time Frame: Baseline, the days 8 and 15.] [Designated as safety issue: No]. Ask the subjects to complete the questionnaire by circling the correct answers and then tally the results based upon the following numerical scale: a =1, b = 2, c = 3, d = 4, e = 5. The sum of the scores for the individual items constitutes the CNAQ score. CNAQ score ≤28 indicates significant risk of at least 5% weight loss within six months.
  • Caloric intake [Time Frame: Baseline, the days 8 and 15.] [Designated as safety issue: No ] The caloric intake will be assessed by the dietician.
  • Functional Assessment of Anorexia/Cachexia Therapy [Time Frame: Baseline, the days 8 and 15.] [Designated as safety issue: No].
  • Functional Assessment of Anorexia/Cachexia Therapy was designed to measure general aspects of quality of life (QOL) as well as specific anorexia/cachexia-related concerns.
  • Nutritional status [Time Frame: Baseline, the days 8 and 15.] [Designated as safety issue: No]. Weight was determined in kilograms. Triceps skinfold (mm), arm circumference(cm), and calf circumference (cm) were determined.
Other Outcome Measures:
  • Edmonton Symptom Assessment Scale [Time Frame: Baseline, the days 8 and 15.] [Designated as safety issue: No] Edmonton Symptom Assessment Scale is a nine-item patient-rated symptom visual analogue scale developed for use in assessing the symptoms of patients receiving palliative care.
  • The Questionnaire of Acupuncture-related Events (QAE) [Time Frame: Baseline and the days 7.] [Designated as safety issue: Yes].
    The side effects and their detail will be record during and after the acupuncture.
Locations and Contacts
Contacts
Zihui Xu, PhD; +86-023-68755615; zihuixu@yeah.net
Ye Cui, MD; +86-023-68774249; cuiyendian@163.com
Locations
China, Chongqing
Chongqing TCM Hospital - Not Recruiting
Jiangbei, Chongqing, China, 402760
Contact:Contact: Jian Li, MD
Principal Investigator: Jing Wang, MD

XinQiao Hosiptal - Recruiting
Shapingba, Chongqing, China, 400037
Contact: Zihui Xu, PhD; zihuixu@yeah.net
Principal Investigator: Haiou Luo, MD

Daping Hospital - Recruiting
Yuzhong, Chongqing, China, 400042
Principal Investigator: Jinglu Shan, MD
More Info clinicaltrials.gov/ct2/show/NCT02619266

This website contains resources related to healthcare professionals (HCP), for educational purposes only ("information"). This is a free service not linked to products or services, and provides no legal or contractual relationships.The information takes into consideration international rules and laws. This area may experience content changes at any time without prior notice to its users. In no event this fact will result in obligations or liabilities to the site. By clicking "Yes, I confirm I am a HCP" you confirm to be a healthcare professional and agree to comply with all the conditions detailed herein.

Yes, I confirm I am a HCP
 
Go Top